ASGE Annual Postgraduate Course: Clinical Challenges and Real-Time Decision Making in GI Endoscopy (Live and Virtual) | May 2023-AbuDayyeh_Challenges encountered with balloon and ESG

AbuDayyeh_Challenges encountered with balloon and ESG

Pdf Summary

In session 8 of the 2023 ASGE Annual Postgraduate Course, Dr. Barham Abu Dayyeh discusses the challenges encountered with balloons and endoscopic sleeve gastroplasty (ESG) in the treatment of obesity. He discloses his connections to various companies and organizations in the field. The lecture emphasizes the unmet need for effective and durable obesity treatments.<br /><br />Dr. Abu Dayyeh discusses the use of endoscopic bariatric and metabolic therapies (EBMTs) as an expanding therapeutic option for obesity, including medications combined with procedures such as ESG. He presents a study on physiological gastric remodeling through endoscopic sleeve gastroplasty.<br /><br />He highlights the FDA authorization of the Apollo ESG and Revise Systems, the first FDA-authorized systems for endoscopic sleeve gastroplasty. These systems are intended for adults with obesity who have not been able to lose weight through diet and exercise alone.<br /><br />The lecture also covers the intragastric balloon procedure and its mechanism of action. Dr. Abu Dayyeh explains the concept of gastric retention and discusses hyperinflation and adjustable intragastric balloons.<br /><br />The session concludes with a question and answer segment allowing participants to engage with Dr. Abu Dayyeh and address any queries or concerns.<br /><br />Overall, the lecture provides insights into the challenges and advancements in the use of balloons and endoscopic procedures for the treatment of obesity.

Keywords

endoscopic sleeve gastroplasty

obesity treatment

endoscopic bariatric and metabolic therapies

physiological gastric remodeling

Apollo ESG

Revise Systems

FDA authorization

intragastric balloon procedure

gastric retention

hyperinflation